OpGen subsidiary Ares Genetics demonstrated feasibility and next generation sequencing based antibiotic susceptibility testing in multi-center study
| | | |

OpGen subsidiary Ares Genetics demonstrated feasibility and next generation sequencing based antibiotic susceptibility testing in multi-center study

On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…